217 related articles for article (PubMed ID: 29701768)
21. Retina-specific loss of
Ueki Y; Shchepetkina V; Lefcort F
Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29929962
[TBL] [Abstract][Full Text] [Related]
22. A humanized IKBKAP transgenic mouse models a tissue-specific human splicing defect.
Hims MM; Shetty RS; Pickel J; Mull J; Leyne M; Liu L; Gusella JF; Slaugenhaupt SA
Genomics; 2007 Sep; 90(3):389-96. PubMed ID: 17644305
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA screening identifies a link between NOVA1 expression and a low level of IKAP in familial dysautonomia.
Hervé M; Ibrahim EC
Dis Model Mech; 2016 Aug; 9(8):899-909. PubMed ID: 27483351
[TBL] [Abstract][Full Text] [Related]
24. Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia.
Cuajungco MP; Leyne M; Mull J; Gill SP; Lu W; Zagzag D; Axelrod FB; Maayan C; Gusella JF; Slaugenhaupt SA
Am J Hum Genet; 2003 Mar; 72(3):749-58. PubMed ID: 12577200
[TBL] [Abstract][Full Text] [Related]
25. Phosphatidylserine increases IKBKAP levels in a humanized knock-in IKBKAP mouse model.
Bochner R; Ziv Y; Zeevi D; Donyo M; Abraham L; Ashery-Padan R; Ast G
Hum Mol Genet; 2013 Jul; 22(14):2785-94. PubMed ID: 23515154
[TBL] [Abstract][Full Text] [Related]
26. Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia.
Axelrod FB; Liebes L; Gold-Von Simson G; Mendoza S; Mull J; Leyne M; Norcliffe-Kaufmann L; Kaufmann H; Slaugenhaupt SA
Pediatr Res; 2011 Nov; 70(5):480-3. PubMed ID: 21775922
[TBL] [Abstract][Full Text] [Related]
27. Developmental regulation of neuronal gene expression by Elongator complex protein 1 dosage.
Morini E; Gao D; Logan EM; Salani M; Krauson AJ; Chekuri A; Chen YT; Ragavendran A; Chakravarty P; Erdin S; Stortchevoi A; Svejstrup JQ; Talkowski ME; Slaugenhaupt SA
J Genet Genomics; 2022 Jul; 49(7):654-665. PubMed ID: 34896608
[TBL] [Abstract][Full Text] [Related]
28. A neuron autonomous role for the familial dysautonomia gene ELP1 in sympathetic and sensory target tissue innervation.
Jackson MZ; Gruner KA; Qin C; Tourtellotte WG
Development; 2014 Jun; 141(12):2452-61. PubMed ID: 24917501
[TBL] [Abstract][Full Text] [Related]
29. Selective retinal ganglion cell loss and optic neuropathy in a humanized mouse model of familial dysautonomia.
Chekuri A; Logan EM; Krauson AJ; Salani M; Ackerman S; Kirchner EG; Bolduc JM; Wang X; Dietrich P; Dragatsis I; Vandenberghe LH; Slaugenhaupt SA; Morini E
Hum Mol Genet; 2022 Jun; 31(11):1776-1787. PubMed ID: 34908112
[TBL] [Abstract][Full Text] [Related]
30. IKBKAP mRNA in peripheral blood leukocytes: a molecular marker of gene expression and splicing in familial dysautonomia.
Gold-von Simson G; Leyne M; Mull J; Rolnitzky LM; Goldberg JD; Berlin D; Axelrod FB; Slaugenhaupt SA
Pediatr Res; 2008 Feb; 63(2):186-90. PubMed ID: 18091349
[TBL] [Abstract][Full Text] [Related]
31. Kinetin in familial dysautonomia carriers: implications for a new therapeutic strategy targeting mRNA splicing.
Gold-von Simson G; Goldberg JD; Rolnitzky LM; Mull J; Leyne M; Voustianiouk A; Slaugenhaupt SA; Axelrod FB
Pediatr Res; 2009 Mar; 65(3):341-6. PubMed ID: 19033881
[TBL] [Abstract][Full Text] [Related]
32. Development of Engineered-U1 snRNA Therapies: Current Status.
Gonçalves M; Santos JI; Coutinho MF; Matos L; Alves S
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834063
[TBL] [Abstract][Full Text] [Related]
33. Exon-Specific U1s Correct SPINK5 Exon 11 Skipping Caused by a Synonymous Substitution that Affects a Bifunctional Splicing Regulatory Element.
Dal Mas A; Fortugno P; Donadon I; Levati L; Castiglia D; Pagani F
Hum Mutat; 2015 May; 36(5):504-12. PubMed ID: 25665175
[TBL] [Abstract][Full Text] [Related]
34. Rescue of spinal muscular atrophy mouse models with AAV9-Exon-specific U1 snRNA.
Donadon I; Bussani E; Riccardi F; Licastro D; Romano G; Pianigiani G; Pinotti M; Konstantinova P; Evers M; Lin S; Rüegg MA; Pagani F
Nucleic Acids Res; 2019 Aug; 47(14):7618-7632. PubMed ID: 31127278
[TBL] [Abstract][Full Text] [Related]
35. Improvement of SMN2 pre-mRNA processing mediated by exon-specific U1 small nuclear RNA.
Dal Mas A; Rogalska ME; Bussani E; Pagani F
Am J Hum Genet; 2015 Jan; 96(1):93-103. PubMed ID: 25557785
[TBL] [Abstract][Full Text] [Related]
36. Bone biomechanical properties and tissue-scale bone quality in a genetic mouse model of familial dysautonomia.
Vahidi G; Flook H; Sherk V; Mergy M; Lefcort F; Heveran CM
Osteoporos Int; 2021 Nov; 32(11):2335-2346. PubMed ID: 34036438
[TBL] [Abstract][Full Text] [Related]
37. Specific correction of a splice defect in brain by nutritional supplementation.
Shetty RS; Gallagher CS; Chen YT; Hims MM; Mull J; Leyne M; Pickel J; Kwok D; Slaugenhaupt SA
Hum Mol Genet; 2011 Nov; 20(21):4093-101. PubMed ID: 21821670
[TBL] [Abstract][Full Text] [Related]
38. Intronic PAH gene mutations cause a splicing defect by a novel mechanism involving U1snRNP binding downstream of the 5' splice site.
Martínez-Pizarro A; Dembic M; Pérez B; Andresen BS; Desviat LR
PLoS Genet; 2018 Apr; 14(4):e1007360. PubMed ID: 29684050
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic strategy to rescue mutation-induced exon skipping in rhodopsin by adaptation of U1 snRNA.
Tanner G; Glaus E; Barthelmes D; Ader M; Fleischhauer J; Pagani F; Berger W; Neidhardt J
Hum Mutat; 2009 Feb; 30(2):255-63. PubMed ID: 18837008
[TBL] [Abstract][Full Text] [Related]
40. The molecular basis of familial dysautonomia: overview, new discoveries and implications for directed therapies.
Rubin BY; Anderson SL
Neuromolecular Med; 2008; 10(3):148-56. PubMed ID: 17985250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
